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Abstract
Background: To explore the gender difference of ALT elevation and its association with high hemoglobin levels.
Methods: A cross-sectional study of 3547 adolescents (2005 females, mean age of 16.5?.3 years) who were negative for
hepatitis B surface antigen received health checkups in 2006. Body mass index (BMI), levels of hemoglobin, ALT and
cholesterol were measured. ALT .42 U/L was defined as elevated ALT. Elevated ALT levels were detected in 112 of the 3547
participants (3.3%), more prevalent in males than in females (5.4% vs. 1.4%, p,0.001). Hemoglobin levels had a significant
linear correlation with ALT levels in both genders. Abnormal ALT started to occur if hemoglobin .11 g/dl in females or
.13.5 g/dl in males, but the cumulative cases of elevated ALT increased more quickly in males. Proportion of elevated ALT
increased as either the BMI or hemoglobin level rise, more apparent in male adolescents. Logistic regression modeling
showed odds ratio (95% confidence interval) were 24.7 (15.0–40.6) for BMI 27 kg/m
2; 5.5 (2.9–10.4) for BMI 24–27 kg/m
2;
2.7 (1.3–5.5) for Q5 (top 20th percentile) hemoglobin level; and 2.6 (1.6–4.1) for male gender. Further separately fitting the
logistic models for two genders, the significance of Q5 hemoglobin level only appeared in the males.
Conclusions: High hemoglobin level is a significant risk factor of ALT elevation after control hepatitis B, obesity and gender.
Males have greater risk of abnormal liver function which may be associated with higher hemoglobin levels.
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Introduction
Male gender has been noted to have a higher risk of elevated
alanine aminotransferase (ALT) in previous epidemiological
studies [1,2,3,4,5]. However, no clear mechanism exists to explain
how sex affects the development of abnormal liver function among
adolescents. In general, male adolescents have higher hemoglobin
levels than those of females, because the latter regularly lose blood
in the menstrual cycle. As males have both higher levels of
hemoglobin and ALT than females, we are interested in the
possible association between hemoglobin and ALT levels among
adolescents and the potential hypothesis of the gender difference.
T h ea i mo ft h i ss t u d yi st oe x p l o r et h eg e n d e rd i f f e r e n c eo fA L T
elevation and its association with hemoglobin levels among adolescents.
Methods
Study Population
To facilitate early detection of morbidity, the Bureau of Health
of the local government in Taiwan has an annual program that
provides a health checkup for all students in the tenth grade in
senior high schools. The Department of Community Health of
Pingtung Christian Hospital took up the responsibility for
performing these checkups in Taitung and Pingtung counties in
southern Taiwan in 2006. A total of 3610 adolescents from 11
senior high schools received physical checkups between August
and October of 2006. The participation rate was nearly 100%, as
the health checkup was mandatory for all students. To avoid any
potential confounding effect from hepatitis B infection, we have
excluded 63 students with positive hepatitis B surface antigen
(HBsAg), 30 males and 33 females, from the analysis. The
remaining 3547 adolescents, 1542 males and 2005 females, had a
mean age and standard deviation of 16.561.3 years.
Laboratory Data and Definitions
Anthropometric measures and blood sampling were done after
an overnight fast. Body height (BH), body weight (BW) and serum
biochemistry including alanine aminotransferase (ALT), aspartate
aminotransferase (AST) and cholesterol levels, were measured and
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Coulter LX-20 autoanalyzer. In our hospital, an ALT level above
42 IU/L was defined as elevated, indicating abnormal biochemical
function of the liver. A cholesterol level over 200 mg/dl was defined
as abnormal. The normal ranges of hemoglobin are 12–16 g/dl for
females and 14–18 g/dl for males. The hemoglobin level of each
gender was classified into 5 quintiles: Q1 (0
th –2 0
th percentiles), Q2
(21
st –4 0
th percentiles), Q3 (41
st –6 0
th percentiles), Q4 (61
st –8 0
th
percentiles), and Q5 (81
st – 100
th percentiles). Hepatitis B markers
including hepatitis B surface antigen (HBsAg) and hepatitis B
surface antibody (anti-HBs) were measured using a radioimmuno-
assay (Abbott Laboratory, U.S.A.) and marked as positive or
negative. BMI (body mass index) was calculated in kg/m
2 and
classified into the following three categories as suggested by the
Department of Health in Taiwan: normal (BMI ,24 kg/m
2),
overweight (BMI 24 but ,27 kg/m
2) and obese (BMI 27 kg/
m
2) categories.
Ethics Statement
The Ethics Review Board of our institute approved the protocol
before the commencement of this study. All participants or their
parents provided us with an informed consent. All data were
collected for statistical analysis only, without revealing any
personal identification.
Statistical Methods
Statistical analysis was performed using SAS version 9.1 (SAS
Institute, Inc., Cary, NC). A p value ,0.05 was considered to
represent a statistically significant difference. Risk factors including
BMI, gender and hemoglobin levels were taken into consideration
as determinants or risk factors in the construction of multivariate
logistic regression models with the level of ALT as the dependent
variable. Adjusted odds ratios (ORs) were estimated and 95%
confidence intervals (95% CI) were also calculated.
Results
Basic Factors Categorized by Gender
The distributions of age, anthropometric measurements (BH,
BW and BMI), hemoglobin levels, ALT, AST, cholesterol and
states of hepatitis B infection of all 3547 adolescents are
summarized and stratified by gender in Table 1. Compared with
female adolescents, male adolescents have significantly higher
values of BH, BW, and BMI, as well as higher levels of ALT, AST
and hemoglobin, but lower cholesterol levels (Table 1). Elevated
ALT was detected in 112 (3.2%) participants, and was more
prevalent in males than in females (5.4% vs. 1.4%, p,0.001).
The linear correlations between the hemoglobin and ALT
levels are significant for two genders (Figure 1). Furthermore, the
cumulative numbers of individuals with abnormal ALT and
hemoglobin levels also yield statistically significant linear
correlations in both genders, with a much steeper slope for
males than that of females (Figure 2). According to the regression
analyses, there seems to be a threshold level for hemoglobin of
which the number of subjects with abnormal ALT begins to
exceed zero, and that level is about 11.0 g/dl for females and
13.5 g/dl for males.
When stratified by gender and BMI classification, we found that
elevated ALT occurs more frequently at higher hemoglobin levels
(Figure 3). There seemed to have a dose-response relationship
between increased proportions of individuals with elevated ALT
and increased hemoglobin levels among males, but not apparent
among female adolescents.
Risk Factors Associated with ALT Elevation
Table 2 compared the odds ratio (OR) and 95% confidence
interval (95% CI) for risk factors associated with elevated ALT
among three different multivariate logistic regression models.
Through such comparisons, we found an effect modification by
gender on the association between increased hemoglobin and
elevated ALT. In other words, the OR is significant for Q5
hemoglobin level in males but not in females. In particular, the
statistically significant risk factors for elevated ALT were
overweight, obesity, Q5 hemoglobin level, and male gender after
adjustment for all other risk factors.
Discussion
For adolescents, the known risk factors of elevated alanine
aminotransferase (ALT) include viral hepatitis infections [6,7,8],
obesity [8,9,10,11], metabolic syndrome [12] and drugs [13]. After
excluding all hepatitis B carriers, this study identifies following risk
factors significantly associated with ALT elevation among
adolescents, including obesity, high hemoglobin level and male
gender. Since the hemoglobin level is generally higher in male
adolescents than that in female adolescents (14.861.1 vs.
13.161.3, p,0.001, Table 1), we suspect the effect of gender
difference on ALT elevation may be related to the difference of
hemoglobin levels between two genders.
Obesity has been reported as a significant risk factor for liver
function impairment and BMI is a good predictor of elevated ALT
[9,10,11,14]. The present study also corroborates the above claim
among adolescents, as summarized in the logistic regression
models in Table 2.
Table 1. Basic information including age, anthropometric
measurements, biochemical data and hepatitis B antibody
status of 3547 adolescents stratified by gender.
Male Female p value
Number (%) 1542 (43.5) 2005 (56.5)
Age (mean 6 S.D.), years 16.661.6 16.461.0 0.675
Body height (mean 6 S.D.), cm 170.466.3 159.465.5 ,0.001
Body weight (mean 6 S.D.), kg 63.8614.4 52.769.8 ,0.001
BMI (mean 6 S.D.) 21.964.5 20.763.6 ,0.001
,24, n (%) 1161 (75.3) 1724 (86.0) ,0.001
24 – 26.9, n (%) 176 (11.4) 157 (7.8)
$27, n (%) 205 (13.3) 124 (6.2)
ALT (mean 6 S.D.), U/L 19.2615.3 14.468.7 ,0.001
.42 U/L, n (%) 83 (5.4) 29 (1.4) ,0.001
#42 U/L, n (%) 1459 (94.6) 1976 (98.6)
Hemoglobin (mean 6 S.D.), g/dl 14.861.1 13.161.3 ,0.001
Cholesterol (mean 6 S.D.), mg/dl 157.6629.3 174.6630.2 ,0.001
.200 mg/dl, n (%) 116 (7.5) 354 (17.7) ,0.001
#200 mg/dl, n (%) 1426 (92.5) 1651 (82.3)
Anti-HBs antibody positive, n (%) 521 (33.8) 765 (38.2) 0.007
Antibody negative, n (%) 1021 (66.2) 1240 (61.8)
Student t-test or Chi square test, with p value ,0.05 as significant.
BMI = body mass index.
ALT = alanine aminotransferase.
AST = aspartate aminotransferase.
S.D. = standard deviation.
doi:10.1371/journal.pone.0013269.t001
Sex Difference of ALT and Hb
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significantly associated with ALT elevation in this study. Although
we found a linear correlation between ALT levels and hemoglobin
levels in Figure 1, such an association becomes more apparent
when the hemoglobin level is above 11.0 g/dl for females and
13.5 g/dl for males as shown in Figure 2. Further analysis by
multivariate logistic regression models in Table 2 found that only
Q5 (in the top 20
th percentile) hemoglobin levels are significantly
associated with a higher risk compared to Q1 (in the bottom 20
th
percentile), with an OR of 2.7 (95% CI, 1.3–5.5). Furthermore,
there appears a dose-response relationship between increased
proportion of individuals with elevated ALT and increased
hemoglobin levels in Figure 3, and such a relationship is the most
apparent in the category of BMI .27 kg/m
2, followed by BMI
24–27 kg/m
2 and the least in BMI ,24 kg/m
2. Therefore, we
think both BMI and hemoglobin levels synergistically contribute to
the elevation of ALT.
For gender effect, this study found a higher percentage of males
with elevated ALT than that of females (5.4% vs. 1.4%, p,0.001,
Table 1). Moreover, the slope of the correlation lines between
accumulated number of individuals with elevated ALT and
hemoglobin level for two genders is steeper for male adolescents
than that for females (22.95 vs. 6.27 in Figure 2), indicating an
effect modification by gender. Different logistic regression models
in Table 2 showed the attempts to clarify the interaction between
gender and hemoglobin level on ALT elevation. In the model 1
with all subjects included, both gender and Q5 hemoglobin level
were significant risk factors for ALT elevation. Further analysis by
separately fitting the logistic models for different genders showed
that the significance of Q5 hemoglobin level only appeared in the
males (Table 2), corroborating the hypothesis of a gender effect.
Furthermore, the figure 3 also supports that increased BMI is a
major risk factor of elevated ALT among males, but not females.
In contrast, cholesterol was found to be associated with elevated
ALT only for females but not males in Table 2.
At the same time, there were 63.7% (61.8% in females and
66.2% in males, p=0.007) adolescents without detectable hepatitis
B antibody (anti-HBs), which is consistent with previous studies in
Taiwan showing approximately a 63–64% undetectable rate of
anti-HBs among adolescents who were born after the implemen-
tation for the universal HBV vaccination program [15,16,17]. All
the above facts corroborate the validity of this study.
Because hepatitis C, another important risk factor for abnormal
liver function, is not endemic in Pingtung and Taitung counties of
Taiwan, and none of these adolescents have ever received blood
transfusion before, it did not appear to be a confounder in this
study. Some infectious agents like hepatitis A, malaria, enteric
fever that may also induce ALT elevation are very rare in Taiwan
which is already a well-developed country with good sanitary
environment. Moreover, these adolescents were apparently well
before the health checkup. So, we did not think these infections
would be confounders. Obstructive sleep apnea as a possible co-
morbidity of bariatric patients with morbid obesity was also
associated with an elevated hemoglobin [18]. Although in our
daily clinical practice, sleep apnea was very rare in Taiwanese
adolescents, we still carefully evaluated each subject. In total, there
were only 8 participating adolescents with BMI over 40 and none
of them suffered from sleep apnea. Moreover, the association
Figure 1. The distribution of alanine aminotransferase (ALT) levels by hemoglobin levels among 3547 adolescents. Two fitting
regression lines of two genders are drawn by cubic equation with statistical significance, p,0.001.
doi:10.1371/journal.pone.0013269.g001
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by BMI categories. So, the sleep apnea cannot be a confounder for
the relationship between a higher hemoglobin and elevated ALT.
In addition, histories of medication, alcohol drinking, drugs or
chemical exposures were evaluated in this study, and none of the
participants had such a problem. Finally, as the prevalence of HFE
gene mutation among Taiwanese healthy people was only 0.33%
of carrier rate [19], and its association with iron overload among
CHC or NAFLD patients was not significant[20], the likelihood of
this alternative explanation is also minimal. Thus, we tentatively
concluded that the major risk factors were captured in this study.
However, the exact mechanism by which high hemoglobin is
associated with elevated ALT remains unclear. To the best of our
knowledge, only one study in Japan found that hemoglobin over
14.0 g/dl was a strong predictor of ALT elevation in severely
obese women [21]. Since the existence of a threshold level for
increased hemoglobin seems to be associated with elevated ALT in
Figure 2 as well as their dose-response relationship in Figure 3, we
suspect that the higher hemoglobin level might serve as a surrogate
marker for a possible overload of iron in the human body, which
has been found to be associated with elevated ALT
[22,23,24,25,26]. It has been approved that regular phlebotomy
to remove excess body iron can improve ALT level among chronic
hepatitis C cases [27,28,29,30,31,32], aid histological recovery in
patients with non-alcoholic fatty liver diseases (NAFLD) [33,34].
Since the menstrual cycle of female adolescents is akin to a
monthly phlebotomy, it may explain why female adolescents in
this study have a much lower prevalence of elevated ALT (Table 1)
and the effect modification by sex in the construction of
multivariate logistic regression models (Table 2).
Some limitations of the present study should be mentioned.
First, the number of subjects with abnormal ALT was relatively
small in both males and females, since these adolescents were
apparently healthy students regularly attending senior high schools
and just received a routine health checkup. As the proportion was
not high, it was not appropriate to draw any strong inference.
Second, since smoking might be related to an increased
hemoglobin and a national survey in 2007 found the smoking
rate among the senior high school students were 14.0% [35], it
raises the concern that smoking might be a potential confounder in
this study. However, as smoking was not associated with ALT
elevation in our previous study [25], and people aged less than 18
years old are not allowed to purchase cigarettes and students are
forbidden to smoke in the high school in Taiwan, the likelihood of
ALT elevation caused by heavy smoking among these adolescent is
probably minimal. Third, this was a cross-sectional study, which
precludes the determination of a causal relationship between
elevated ALT level and the associated factors. Fourth, due to
budget constraints, we did not perform ultrasonography to help
diagnose fatty liver or NAFLD. Instead, we used elevated ALT
level as a proxy indicator in our daily practice for screening.
In conclusion, the current study indicates that obesity, Q5
hemoglobin level (top 20
th percentile) and male gender might be
associated with elevated ALT among Taiwanese adolescents.
Furthermore, the significance of Q5 hemoglobin level only
appeared in male adolescents, indicating the high hemoglobin
level may be a potential risk factor for elevated ALT, especially for
male adolescents. However, further study is needed to test the
association between high hemoglobin and possible iron overload
and the increased risk of elevated ALT in adolescents.
Figure 2. The cumulative number of individuals with abnormal ALT has a linear correlation with the hemoglobin levels for both
genders, with both regression lines being statistically significant. The slope of the regression line is higher for males than for females: 22.95
vs. 6.27. According to the regression lines, the hemoglobin levels at which the cumulative number of abnormal ALT would be zero, are about 11.0 g/
dl for females and 13.5 g/dl for males.
doi:10.1371/journal.pone.0013269.g002
Sex Difference of ALT and Hb
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quintiles of hemoglobin levels by gender. The total numbers of individuals with abnormal ALT are 29 and 83 cases among 2005 females and
1542 males, respectively.
doi:10.1371/journal.pone.0013269.g003
Table 2. Comparisons of odds ratio (OR) and 95% confidence interval (95%CI) for risk factors associated with elevated alanine
aminotransferase (ALT) among different logistic regression models.
ALT, U/L
.42/#42
Model 1=
All subjects
OR (95%CI)
Model 2A =
Male adolescents
OR (95%CI)
Model 2B = Female
adolescents
OR (95%CI)
Gender
Female 29/1976 1
Male 83/1459 2.6 (1.6–4.1)
Body mass index, kg/m
2
,24 24/2885 1 1 1
24–26.9 15/333 5.5 (2.9–10.4) 5.9 (2.7–12.8) 4.3 (1.3–14.0)
$27 73/329 24.7 (15.0–40.6) 25.1 (13.4–47.0) 24.5 (10.6–56.4)
Cholesterol, mg/dl
#200 83/2994 1 1 1
.200 29/441 1.8 (1.1–2.9) 1.5 (0.8–2.8) 2.4 (1.1–5.6)
Hemoglobin, g/dl
Q1 11/699 1 1 1
Q2 16/691 1.4 (0.6–3.1) 1.3 (0.4–3.8) 1.6 (0.5–5.0)
Q3 14/696 1.0 (0.4–2.3) 1.6 (0.6–4.5) 0.4 (0.1–1.9)
Q4 22/685 1.3 (0.6–2.8) 1.8 (0.7–4.9) 0.7 (0.2–2.6)
Q5 49/664 2.7 (1.3–5.5) 3.8 (1.5–9.7) 1.4 (0.5–4.6)
doi:10.1371/journal.pone.0013269.t002
Sex Difference of ALT and Hb
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